期刊
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
卷 32, 期 -, 页码 1-9出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jddst.2016.01.004
关键词
Chitosan nanoparticles; Pravastatin; Characterization; In vitro release; Cytotoxicity
资金
- Kayyali Chair for Pharmaceutical Industry, Department of Pharmaceutics, College of Pharmacy, King Saud University [G-2015-1]
Pravastatin (PRV) loaded Chitosan nanoparticles (PRV/CSNPs) were employed as a novel carriers for liver cancer treatment. These nanoparticles were prepared by an ionic gelation method and characterized by FTIR and XRD. The prepared nanoparticles showed the spherical shape of nanoparticles having an average size of 129.8 +/- 10.5-270.4 +/- 23.3 nm, PDI in the range of 0.238 +/- 0.03-0.452 +/- 0.05 and zeta potential between 25.1 +/- 2.6 and 33.5 +/- 2.7 mV. The PRV entrapment efficiency of CSNPs was in the range of 49.05-72.04%. The in vitro release studies showed an initial rapid PRV release up to 6 h followed by a slow release ranging from 52 to 92% after 48 h following Higuchi's model kinetics. The in vitro cytotoxicity of PRV/CSNPs showed 51% HepG2 growth inhibition compared to 38% of free PRV after 72 h incubation. PRV/CSNPs can be considered as a promising carrier for cancer therapy. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据